Triple Antibiotic
- Product NDC
- 70000-0058
- 11-digit product format
- 700000058
- Labeler code
- 70000
- Product ID
- 70000-0058_b4dafaad-ab7e-45e0-9e46-838887ca60da
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin Zinc, Neomycin Sulfate, Polymyxin-B Sulfate
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Cardinal Health (Leader) 70000
- Application
- part333B
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2020-12-31
- Marketing end
- 0000-00-00
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- Active strength
- 400 [iU]/g; mg/g; [iU]/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70000-0058 | TRIPLE ANTIBIOTIC (BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE) OINTMENT [CARDINAL HEALTH (LEADER) 70000] | 4 | Legacy NDC | 20231118_edff4443-d25e-43dc-a788-5ba23d6bf231.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70000-0058-1 | 70000005801 | 1 TUBE in 1 CARTON (70000-0058-1) > 28 g in 1 TUBE | 1 tube | 2020-12-31 | 0000-00-00 | No | No | Current |